Home/Filings/4/0001178913-24-001421
4//SEC Filing

Galitzer Hillel 4

Accession 0001178913-24-001421

CIK 0001638097other

Filed

Apr 22, 8:00 PM ET

Accepted

Apr 23, 5:30 PM ET

Size

7.4 KB

Accession

0001178913-24-001421

Insider Transaction Report

Form 4
Period: 2024-04-19
Galitzer Hillel
Chief Operating Officer
Transactions
  • Award

    Stock Option (right to buy)

    2024-04-19+130,000130,000 total
    Exercise: $1.99Exp: 2034-04-19Ordinary Shares, par value NIS 0.0000769 per share (130,000 underlying)
  • Award

    Ordinary Shares, par value NIS 0.0000769 per share

    2024-04-19+30,15164,257 total
Footnotes (2)
  • [F1]Represent a grant of stock-settled restricted stock units. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 19, 2024.
  • [F2]The options vest over a three-year period with 33% of the options vesting on April 19, 2025, the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining two-year period.

Documents

1 file

Issuer

Entera Bio Ltd.

CIK 0001638097

Entity typeother

Related Parties

1
  • filerCIK 0001904740

Filing Metadata

Form type
4
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 5:30 PM ET
Size
7.4 KB